top of page

Pro PG receives S19 A for Imipramine 25mg Tablets - Extended until 31st August

Updated: Jul 12, 2021


​Pro Pharmaceuticals Group has received the Section 19A approval for supply of Imipramine 25mg Tablets until 30th June 2021.


Import and supply approved until: 31st August 2021 (now extended)

Imipramine 25mg tablets are currently experiencing a shortage of supply in Australia with Tofranil 25mg not available. This shortage is expected to continue until Mid 2021.

Product: IMIPRAMINE HYDROCHLORIDE TABLETS USP, 25 MG 100 TABLETS (LEADING PHARMA LLC) S19a​

Stock availability: On hand

PBS Listing September 1st 2020 PBS Code: 12113M

Ordering

Orders can be placed via Wholesalers Symbion via the below PDE numbers.

PDE: 692379

Or via our website www.propg.com.au , email: orders@propg.com.au or phone: 1300 077 674


 
 
Recent Posts
Archive
Search By Tags
Follow Us
  • Twitter Social Icon
  • Google+ Basic Square

Legal & Trademark Notice
© 2026 Pro Pharmaceuticals Group Pty Ltd. All rights reserved.
Pro PG, CheckMed, and their respective logos are registered trademarks owned worldwide by Pro Pharmaceuticals Group Pty Ltd.
Pro Pharmaceuticals Group operates globally through associated entities, including CTS Pharmaceuticals Pty Ltd (Australia), Jemstar Sp. z o.o. (Poland), and Pro Pharmaceuticals Group NZ Ltd (New Zealand).

International Tax Registrations:
ABN 20 605 457 430 (Australia) | VAT DE401757398 (EU VAT ID) | Steuernummer 15/460/00493 (Germany) | VAT PL5263362401 (Poland) | VAT NL825524295B01 (Netherlands).

bottom of page